A Study in Adults With Cutaneous T-cell Lymphoma (CTCL) Retreated With Brentuximab Vedotin

Clinical trial NCT05886478 · COMPLETED

Trial details

NCT number: NCT05886478
Sponsor: Takeda
Status: COMPLETED
Study type: OBSERVATIONAL

T-Cell Lymphoma

Start date: 2024-02-08
Primary completion: 2024-10-31
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.